MiMedx Group, Inc. (MDXG)

MiMedx Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	352.38	348.88	321.48	267.84	242.02	248.23
Revenue Growth (YoY)	5.34%	8.52%	20.03%	10.67%	-2.50%	-17.05%
Cost of Revenue	63.64	60.07	54.63	48.32	39.63	39.33
Gross Profit	288.73	288.81	266.84	219.53	202.39	208.9
Selling, General & Admin	220.92	216.39	216.3	220.85	198.64	240.49
Research & Development	12.83	12.34	12.67	12.7	9.93	11.72
Operating Expenses	234.42	229.5	229.73	234.25	209.39	253.28
Operating Income	54.31	59.31	37.12	-14.73	-7	-44.37
Interest Expense	-3.44	-3.94	-6.58	-5.05	-4.98	-8.27
Interest & Investment Income	3.23	2.93	0.12	0.03	-	0.33
Other Non Operating Income (Expenses)	-0.61	-0.57	-0.03	-0	-0.02	-0
EBT Excluding Unusual Items	53.49	57.74	30.63	-19.75	-12	-52.32
Asset Writedown	-0.39	-0.45	-	-	-0.05	-1.03
Other Unusual Items	1.4	-	-	-	-	-8.2
Pretax Income	54.5	57.29	30.63	-19.75	-12.05	-61.54
Income Tax Expense	14.54	15.3	-36.81	0.21	0.25	-12.26
Earnings From Continuing Operations	39.96	42	67.44	-19.95	-12.3	-49.28
Earnings From Discontinued Operations	0.22	0.42	-9.21	-10.24	2.02	-
Net Income	40.18	42.42	58.23	-30.2	-10.29	-49.28
Preferred Dividends & Other Adjustments	-	-	11.64	6.58	6.14	34.04
Net Income to Common	40.18	42.42	46.59	-36.78	-16.42	-83.33
Net Income Growth	-44.56%	-27.15%	-	-	-	-
Shares Outstanding (Basic)	147	147	116	113	110	108
Shares Outstanding (Diluted)	149	149	146	113	110	108
Shares Change (YoY)	-3.82%	2.11%	29.27%	2.32%	1.94%	1.23%
EPS (Basic)	0.27	0.29	0.40	-0.33	-0.15	-0.77
EPS (Diluted)	0.27	0.28	0.36	-0.33	-0.15	-0.77
EPS Growth	-38.83%	-22.18%	-	-	-	-
Free Cash Flow	64.6	64.51	24.79	-19.41	-5.2	-34.49
Free Cash Flow Per Share	0.43	0.43	0.17	-0.17	-0.05	-0.32
Gross Margin	81.94%	82.78%	83.00%	81.96%	83.63%	84.16%
Operating Margin	15.41%	17.00%	11.54%	-5.50%	-2.89%	-17.88%
Profit Margin	11.40%	12.16%	14.49%	-13.73%	-6.78%	-33.57%
Free Cash Flow Margin	18.33%	18.49%	7.71%	-7.25%	-2.15%	-13.89%
EBITDA	62.81	65.35	40.54	-10.68	-1.82	-37.52
EBITDA Margin	17.82%	18.73%	12.61%	-3.99%	-0.75%	-15.11%
D&A For EBITDA	8.5	6.04	3.43	4.05	5.18	6.86
EBIT	54.31	59.31	37.12	-14.73	-7	-44.37
EBIT Margin	15.41%	17.00%	11.54%	-5.50%	-2.89%	-17.88%
Effective Tax Rate	26.67%	26.70%	-	-	-	-
Advertising Expenses	-	0.6	0.6	0.2	0.1	0.1

Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q